Are Transglutaminase 2 Inhibitors Able to Reduce Gliadin-Induced Toxicity Related to Celiac Disease? A Proof-of-Concept Study
about
Non-dietary methods in the treatment of celiac diseaseLatest in vitro and in vivo models of celiac disease.Advances in the treatment of coeliac disease: an immunopathogenic perspective.Current status of drugs in development for celiac disease.Emerging drugs for coeliac disease.Transglutaminase as a therapeutic target for celiac disease.Celiac disease 2015 update: new therapies.Intestinal barrier dysfunction: implications for chronic inflammatory conditions of the bowel.Current and novel therapeutic strategies in celiac disease.Physiopathology and Management of Gluten-Induced Celiac Disease.Calcium glycerophosphate preserves transepithelial integrity in the Caco-2 model of intestinal transport.Celiac disease: a challenging disease for pharmaceutical scientists.The gliadin peptide 31-43 exacerbates kainate neurotoxicity in epilepsy models.Extra-Intestinal Manifestation of Celiac Disease in Children.Biological functionalities of transglutaminase 2 and the possibility of its compensation by other members of the transglutaminase family.
P2860
Q26863359-03D217A7-63C0-4C35-8D9C-20960B4D47AAQ38072065-53B8A4F0-C0A5-4E56-84C5-B97627B3EB04Q38126789-BC38A92D-C2A7-4235-B00E-EF41847A11A7Q38210088-9B1D887F-A15B-46C8-930C-DD0FF396371EQ38248960-A14AB03B-6D69-4F91-8C4D-E307A9D910C3Q38269678-B106186F-5D32-4664-8AFC-8AE3D38397EFQ38416745-6DDFF94D-1B21-489D-8151-1D41ECA60BD3Q38810502-C5B1F2C0-6BE8-45E5-B1A2-947F9A6DC6BCQ38870456-8E895D01-FEE7-47C5-8C5B-E0DC3972B7ECQ39111493-48B09F9A-647D-42F5-966F-B38FC5F4B67CQ42434492-2E8A634A-D4BE-460D-87C2-F28ADA873D04Q45254873-AF88D7E5-B6F9-41E8-BBAB-0EF8777E658BQ47105415-C21460C3-5BEB-498E-A653-275A0819842DQ55483617-D293A3D3-4796-4A9A-9FAD-8A2FE1EB33D7Q55499802-5CC66B1D-490C-46F3-BA50-74158E727132
P2860
Are Transglutaminase 2 Inhibitors Able to Reduce Gliadin-Induced Toxicity Related to Celiac Disease? A Proof-of-Concept Study
description
article
@en
im August 2012 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована в серпні 2012
@uk
name
Are Transglutaminase 2 Inhibit ...... ease? A Proof-of-Concept Study
@en
Are Transglutaminase 2 Inhibit ...... ease? A Proof-of-Concept Study
@nl
type
label
Are Transglutaminase 2 Inhibit ...... ease? A Proof-of-Concept Study
@en
Are Transglutaminase 2 Inhibit ...... ease? A Proof-of-Concept Study
@nl
prefLabel
Are Transglutaminase 2 Inhibit ...... ease? A Proof-of-Concept Study
@en
Are Transglutaminase 2 Inhibit ...... ease? A Proof-of-Concept Study
@nl
P2093
P2860
P50
P1476
Are transglutaminase 2 inhibit ...... ease? A proof-of-concept study
@en
P2093
Katri Kaukinen
Katri Lindfors
Markku Mäki
Mikko Oittinen
Rami Kivistö
Tiina Rauhavirta
P2860
P2888
P304
P356
10.1007/S10875-012-9745-5
P577
2012-08-10T00:00:00Z